ZA200801635B - Use of hydroxybenzoic acid ester and analogues for the manufacture of a medicament for the prevention and treatment of virus infection - Google Patents

Use of hydroxybenzoic acid ester and analogues for the manufacture of a medicament for the prevention and treatment of virus infection

Info

Publication number
ZA200801635B
ZA200801635B ZA200801635A ZA200801635A ZA200801635B ZA 200801635 B ZA200801635 B ZA 200801635B ZA 200801635 A ZA200801635 A ZA 200801635A ZA 200801635 A ZA200801635 A ZA 200801635A ZA 200801635 B ZA200801635 B ZA 200801635B
Authority
ZA
South Africa
Prior art keywords
analogues
medicament
prevention
manufacture
treatment
Prior art date
Application number
ZA200801635A
Other languages
English (en)
Inventor
Qin Weihua
Original Assignee
Shenghua Guangzhou Pharmace
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenghua Guangzhou Pharmace filed Critical Shenghua Guangzhou Pharmace
Publication of ZA200801635B publication Critical patent/ZA200801635B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA200801635A 2005-08-02 2008-02-19 Use of hydroxybenzoic acid ester and analogues for the manufacture of a medicament for the prevention and treatment of virus infection ZA200801635B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100122870A CN100427082C (zh) 2005-08-02 2005-08-02 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用

Publications (1)

Publication Number Publication Date
ZA200801635B true ZA200801635B (en) 2009-06-24

Family

ID=37698614

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801635A ZA200801635B (en) 2005-08-02 2008-02-19 Use of hydroxybenzoic acid ester and analogues for the manufacture of a medicament for the prevention and treatment of virus infection

Country Status (21)

Country Link
EP (1) EP1930002B1 (da)
JP (1) JP5473328B2 (da)
KR (1) KR100922605B1 (da)
CN (1) CN100427082C (da)
AP (1) AP2658A (da)
AU (1) AU2006275232B2 (da)
BR (1) BRPI0616536B8 (da)
CA (1) CA2617659C (da)
CY (1) CY1117480T1 (da)
DK (1) DK1930002T3 (da)
EA (1) EA016576B1 (da)
ES (1) ES2567130T3 (da)
HU (1) HUE027244T2 (da)
IL (1) IL189162A (da)
MX (1) MX2008001673A (da)
NZ (1) NZ566153A (da)
PL (1) PL1930002T3 (da)
SI (1) SI1930002T1 (da)
UA (1) UA90159C2 (da)
WO (1) WO2007014515A1 (da)
ZA (1) ZA200801635B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603522B (zh) * 2011-01-23 2015-04-22 复旦大学 苯酚类衍生物及其在制备抗乙肝病毒药物中的用途
KR101401154B1 (ko) * 2011-02-22 2014-05-30 경희대학교 산학협력단 메틸 갈레이트를 포함하는 조절 ｔ 세포 활성 억제용 약학적 조성물
PL404138A1 (pl) * 2013-05-31 2014-12-08 Warszawski Uniwersytet Medyczny Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
CN103599093B (zh) 2013-11-18 2016-06-01 中国医学科学院生物医学工程研究所 一种抗hpv药物制剂及用途
CN104784324A (zh) * 2014-05-15 2015-07-22 刘善奎 治疗宫颈糜烂中药栓剂的制法
JP6876066B2 (ja) * 2015-12-18 2021-05-26 タレンゲン インターナショナル リミテッドＴａｌｅｎｇｅｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｉｍｉｔｅｄ 子宮膣部びらんを予防及び治療するための方法
WO2017101873A1 (zh) 2015-12-18 2017-06-22 深圳瑞健生命科学研究院有限公司 一种预防或治疗放射性和化学性损伤的方法
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
WO2019087884A1 (ja) * 2017-10-31 2019-05-09 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
JPWO2019087888A1 (ja) * 2017-10-31 2020-11-12 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
WO2019087881A1 (ja) * 2017-10-31 2019-05-09 富士フイルム株式会社 抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
CN111419833B (zh) * 2020-06-02 2023-04-07 上海爱启医药技术有限公司 没食子酸的药物应用
CN114146078B (zh) * 2020-09-07 2025-09-16 盈科瑞（横琴）药物研究院有限公司 对羟基苯甲酸乙酯抗冠状病毒感染的应用
CN114146082B (zh) * 2020-09-07 2025-09-05 盈科瑞（横琴）药物研究院有限公司 对羟基苯甲酸甲酯及其钠盐抗冠状病毒的用途
CN112375803B (zh) * 2020-11-16 2024-05-07 石河子大学 五倍子中抗炎活性成分没食子酸乙酯的筛选方法及其用途
CN118489806A (zh) * 2024-05-13 2024-08-16 浙江大学 多酚在制备预防和/或缓解动物锌过载所致肠道免疫应激或肠道损伤制剂中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929985A (en) * 1974-01-18 1975-12-30 Richardson Merrell Inc Anhydrous candicidin foam compositions
JPS62132824A (ja) 1985-12-05 1987-06-16 Eisai Co Ltd 肝炎への治療剤
SE464167B (sv) * 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
CN1042298C (zh) * 1989-07-31 1999-03-03 安纳利蒂康有限公司 含鬼臼毒的乳膏形式的药物组合物的制备方法
CN1068782A (zh) * 1992-01-30 1993-02-10 展静 轮胎气压报警装置
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
DE19514694A1 (de) 1995-04-13 1996-10-17 Ina Dr Levi Breitspektrum-Antiinfektivamittel
JPH0959151A (ja) 1995-08-24 1997-03-04 Kao Corp ＮＦ−κＢ活性化抑制剤
CN1068782C (zh) * 1996-04-18 2001-07-25 中国医药研究开发中心 以栾树提取物为有效组分的抗癌药物及制备方法
JPH09328404A (ja) * 1996-06-07 1997-12-22 Iwao Hishida 殺菌、抗菌および不活化剤
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
TR200402446T4 (tr) * 2001-05-03 2004-12-21 Farmigea S.P.A. Servik aşınmanın tedavisi için sükralfatın kullanımı.

Also Published As

Publication number Publication date
KR20080036128A (ko) 2008-04-24
DK1930002T3 (da) 2016-04-11
BRPI0616536B8 (pt) 2021-05-25
IL189162A (en) 2014-04-30
JP2009502985A (ja) 2009-01-29
UA90159C2 (ru) 2010-04-12
ES2567130T3 (es) 2016-04-20
JP5473328B2 (ja) 2014-04-16
BRPI0616536A2 (pt) 2012-12-25
CN100427082C (zh) 2008-10-22
HUE027244T2 (en) 2016-09-28
PL1930002T3 (pl) 2016-07-29
CA2617659A1 (en) 2007-02-08
CY1117480T1 (el) 2017-04-26
EP1930002B1 (en) 2016-01-06
HK1113747A1 (en) 2008-10-17
AU2006275232A1 (en) 2007-02-08
AU2006275232B2 (en) 2010-12-02
EP1930002A4 (en) 2010-04-21
AP2658A (en) 2013-05-09
KR100922605B1 (ko) 2009-10-21
CA2617659C (en) 2013-02-26
EA200800467A1 (ru) 2008-10-30
EA016576B1 (ru) 2012-06-29
IL189162A0 (en) 2008-08-07
SI1930002T1 (sl) 2016-06-30
CN1907276A (zh) 2007-02-07
NZ566153A (en) 2011-07-29
WO2007014515A1 (en) 2007-02-08
MX2008001673A (es) 2008-11-06
EP1930002A1 (en) 2008-06-11
BRPI0616536B1 (pt) 2020-05-26

Similar Documents

Publication Publication Date Title
ZA200801635B (en) Use of hydroxybenzoic acid ester and analogues for the manufacture of a medicament for the prevention and treatment of virus infection
IL177914A0 (en) Use of indazolecarboxamide derivatives for the preparation of a medicament that is intended for the treatment and prevention of paludism
ZA200803493B (en) Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection
ZA200700771B (en) Vaccine for prevention and treatment of HIV-infection
IL186435A0 (en) Oral pharmaceutical formulations comprising fenofibric acid and/or its salts
IL186194A0 (en) Markers associated with the therapeutic efficacy of glatiramer acetate
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
IL178302A (en) Use of Natalizumab in the preparation of a drug to reduce the need for steroid therapy
IL200278A (en) Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness
IL184037A0 (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
TWI369210B (en) Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies
IL187632A (en) 17 – Ethinyl – 17 – Hydroxy – 13 – Methyl – 17,16,15,14,13,12,11,9,8,7 – Dachahydro – 6 h– Cyclopentane [a] Penanthran – 3 – Ilmethyl ester of acetoxy acid Acetic, a pharmaceutical dosage unit containing it and its use in the preparation of a contraceptive
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
EP1902715A3 (en) Use of paliperidone for the treatment of psychiatric patients with reduced hepatic function
PL2640364T3 (pl) Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych
EP2392336A3 (en) Use of 24-norUDCA
ZA200806949B (en) Medicinal formulation for the treatment for hepatitis C
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
EP2065049A4 (en) USE OF SOLIDAGO VIRGAUREA IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF A VIRUS
IL198291A0 (en) Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases
IL191208A (en) Use of phenofibrate or its derivative for the preparation of a drug for the treatment of diabetic retinopathy
WO2008050362A3 (en) Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies
EP1864671A4 (en) USE OF HYDROCHLORIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HYPERTENSION
IL185548A0 (en) Medical uses of 39-desmethoxyrapamycin and analogues thereof
IL186916A0 (en) Use of insp052 polypeptide for the preparation of a medicament for treating diseases